Leah Burns
About Leah Burns
Leah Burns is the Group Director of Real World Evidence Strategy at Bristol Myers Squibb, with over 15 years of experience in real world evidence strategy, outcomes research, and data sciences.
Current Role at Bristol Myers Squibb
Leah Burns holds the position of Group Director, Real World Evidence Strategy at Bristol Myers Squibb in Princeton, New Jersey. In this role, she leads enterprise-level Real World Evidence (RWE) initiatives with an emphasis on regulatory use. She is responsible for overseeing and directing strategies that influence regulatory decisions.
Previous Roles at Bristol Myers Squibb
Leah Burns has held several key positions at Bristol Myers Squibb over her extensive career. From 2013 to 2018, she served as Director of the Center for Observational Research and Data Sciences (CORDS) in Hopewell, NJ. Additionally, she led the Pharmacodiagnostics Center of Excellence as the GHEOR Lead from 2013 to 2016, and from 2011 to 2013, she was the Director of Global Health Economics and Outcomes Research, Neuroscience. Leah also worked as an Associate Director from 2003 to 2011.
Industry and Academic Experience
Leah Burns has a wealth of industry and academic experience. Prior to her roles at Bristol Myers Squibb, she worked at Antigenics as a Clinical Research professional from 2003 to 2005. She also held the position of Research Associate at MSKCC from 1998 to 2005, and worked at Taro Pharmaceuticals from 1998 to 2000.
Educational Background
Leah Burns studied at Columbia University Mailman School of Public Health, where she earned her Master of Public Health (MPH) in Epidemiology from 1998 to 2003. She also holds a Bachelor of Science (BS) in Biology from Fairfield University, where she studied from 1992 to 1996.
Expertise and Skills
With over 15 years of experience, Leah Burns specializes in real world evidence strategy, outcomes research, economic evaluations, and data sciences across multiple therapeutic areas. She possesses strong research and analytical skills and is proficient in communicating scientific information to both internal and external stakeholders, including health and regulatory authorities. She has also served as an industry representative for national research and policy initiatives.